Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-31 @ 10:56 AM
Study NCT ID:
NCT03177460
Status:
COMPLETED
Last Update Posted:
2024-05-03
First Post:
2017-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-01
First Submit QC Date:
None
Study First Post Date:
2017-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-02
Last Update Post Date:
2024-05-03
Last Update Post Date Type:
ACTUAL